Correlation Between Oncolytics Biotech and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncolytics Biotech and Seres Therapeutics, you can compare the effects of market volatilities on Oncolytics Biotech and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Seres Therapeutics.
Diversification Opportunities for Oncolytics Biotech and Seres Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Oncolytics and Seres is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Oncolytics Biotech and Seres Therapeutics
Given the investment horizon of 90 days Oncolytics Biotech is expected to under-perform the Seres Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Oncolytics Biotech is 1.79 times less risky than Seres Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Seres Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 113.00 in Seres Therapeutics on August 24, 2024 and sell it today you would lose (40.00) from holding Seres Therapeutics or give up 35.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncolytics Biotech vs. Seres Therapeutics
Performance |
| Timeline |
| Oncolytics Biotech |
| Seres Therapeutics |
Oncolytics Biotech and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncolytics Biotech and Seres Therapeutics
The main advantage of trading using opposite Oncolytics Biotech and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Oncolytics Biotech vs. Scpharmaceuticals | Oncolytics Biotech vs. Milestone Pharmaceuticals | Oncolytics Biotech vs. Seres Therapeutics | Oncolytics Biotech vs. DiaMedica Therapeutics |
| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |